086 - Management of Bivalirudin for Primary Anticoagulation in Neonatal Respiratory ECMO Therapy within the Children’s Hospitals Neonatal Consortium

Sandy Johng, Seattle Children's Hospital, Seattle, WA, United States; Robert DiGeronimo, Seattle Children's, Seattle, WA, United States; Mihai Puia-Dumitrescu, University of Washington School of Medicine, Seattle, WA, United States; Sarah Handley, University of Washington School of Medicine, Seattle, WA, United States; Zeenia Billimoria, University of Washington School of Medicine, Seattle, WA, United States; Katrin Lichtsinn, Seattle Children's, Seattle, WA, United States; Larissa A.. Yalon, Seattle Children's Hospital, Seattle, WA, United States; James Connelly, Children’s Hospital of Philadelphia, Philadelphia, PA, United States; Nicholas Carr, Intermountain Health, Sandy, UT, United States; Carly Heyrend, Primary Children's Hospital, Salt Lake City, UT, United States; Franscesca Miquel-Verges, University of Arkansas for Medical Sciences, Little Rock, AR, United States; David McCulley, University of California, San Diego School of Medicine, San Diego, CA, United States; Michelle Yang, University of Utah School of Medicine, Salt Lake City, UT, United States; Leslie Lusk, Benioff Children's Hospital Oakland, Oakland, CA, United States; Sharada H. Gowda, Baylor College of Medicine, Houston, TX, United States; Kelsey A.. Montgomery, Riley Hospital for Children at Indiana University Health, Indianapolis, IN, United States; Natalie Rintoul, Childrens Hospital of Philadelphia, Philadelphia, PA, United States